Akso Health (AHG) Return on Capital Employed (2018 - 2019)
Akso Health (AHG) reported Return on Capital Employed of 37.92% for Q3 2019, down 8488.0% on a YoY basis from 0.45% in Q3 2018, and down 579.59% quarter-over-quarter from 5.58% in Q1 2019.
Akso Health (AHG) Return on Capital Employed (2018 - 2019) Analysis & Trends
Akso Health has reported Return on Capital Employed for 2 years, with the latest figure at 37.92% in Q3 2019.
- For the quarter ending Q3 2019, Return on Capital Employed fell 8488.0% year-over-year to 37.92%; the trailing twelve-month figure through Sep 2019 stood at 37.92% (down 8488.0% YoY), and the FY2025 full-year result was 100.99%, down 8987.0% from the prior year.
- Return on Capital Employed for Q3 2019 stood at 37.92%, down from 5.58% in the prior quarter.
- The five-year high for Return on Capital Employed was 67.02% in Q2 2018, with the low at 37.92% in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 38.25% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 11.68% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 15.02% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 8.29% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -1.96% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -67.42% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.62% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -18.00% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -37.92% |
| Mar 31, 2019 | -5.58% |
| Dec 31, 2018 | 21.09% |
| Sep 30, 2018 | 46.96% |
| Jun 30, 2018 | 67.02% |